Lung volume reduction surgery (LVRS) has been demonstrated to improve lung
function, exercise tolerance and quality of life. However, the duration of
improvement is unknown. While the maximal duration of improvement cannot be
determined at this time due to an inadequate period of follow-up, we have
observed in some patients significant and relatively rapid declines in gain
s following LVRS. We describe 6 patients who increased FEV1 by at least 10%
of the predicted value after LVRS and subsequently experienced rapid loss
of the increment in FEV1 (mean loss 79%, 95% CI 58-100%) over a period rang
ing from 14 to 20 months following surgery.